Every announcement Shilpa Medicare has filed with the exchanges that we have reported, newest first. Each story links the original filing.
Price
₹939.9
Market Cap
₹18,382.73 Cr
Revenue TTM
₹1,682.47 Cr
P/E (TTM)
61.83×
Sector 49.16×
Reference data from Trendlyne, as of the most recent story. Not a valuation or a recommendation.
Shilpa Medicare Secures SEC Approval for World-First OERIS Long-Acting Injectable
Shilpa Medicare receives SEC approval for OERIS, a world-first 5-day extended-release ondansetron injection with Indian patent protection valid until…
Shilpa Medicare Commissions Integrated ADC Drug Facility; Net Profit Surges 642%
Shilpa Medicare commissions an integrated ADC drug substance GMP facility in Dharwad, positioning it as a global CDMO partner with ₹11,561 Cr market …
Shilpa Medicare Commissions Integrated ADC Manufacturing Facility in Dharwad
Shilpa Medicare commissions a state-of-the-art ADC GMP manufacturing facility in Dharwad. The new plant enhances CDMO capabilities in the oncology sp…
Shilpa Medicare Subsidiary Commissions Integrated ADC GMP Facility in Dharwad
Shilpa Medicare subsidiary Shilpa Biologicals commissions an ADC GMP facility in Dharwad; the parent company reports a TTM revenue of 1,538.14 crore …
Track Shilpa Medicare in real time
ALFA Finder watches NSE & BSE filings 24/7 and alerts you the moment Shilpa Medicare files something material.
Start Free — 15-day trial